Today: 29 April 2026
Westlake (WLK) stock steadies near $80 after a 7% jump as analysts reset targets
9 January 2026
1 min read

Westlake (WLK) stock steadies near $80 after a 7% jump as analysts reset targets

New York, Jan 9, 2026, 11:45 EST — Regular session

  • Westlake shares were up about 0.8% on Friday, coming off a 6.8% jump in the previous session
  • Mizuho raised its price target to $88, while BofA cut its target to $82 and still kept a buy rating
  • Investors are watching late-February earnings for hints on 2026 demand and pricing

Westlake Corp shares added to Friday’s gains, keeping Thursday’s sharp rebound going as investors digested new analyst target changes. The stock was up about 0.8% at $80.20 after jumping 6.8% on Thursday, and it traded between $78.49 and $81.19 during the session.

Westlake is worth watching here: it’s caught between U.S. housing and global industrial demand, two forces that have whipsawed chemical makers in recent quarters. The Houston-based group sells chemicals, polymers and building products, which keeps the stock exposed to swings in construction activity and commodity pricing.

BofA Securities this week cut its Westlake price target to $82 from $83 and reiterated a buy rating, analyst Matthew DeYoe said. He warned of another year of “growing oversupply” in commodities, but cited potential catalysts including firmer PMI readings — a survey-based gauge of factory activity — rate cuts and capacity rationalization in China. Still, the note said those supports were “too new to rely on.” TipRanks

In a separate update, Mizuho lifted its price target on Westlake to $88 from $82 and kept an outperform rating, according to a GuruFocus report. A price target is an analyst’s estimate of where a stock could trade over the next year, and “outperform” flags an expectation the shares will beat peers or the broader market. GuruFocus

Brokerages have been busily revising their calls after Westlake earlier this week wrapped up its purchase of the ACI/Perplastic Group’s global compounding solutions businesses, according to a filing. Westlake said the transaction was complete in an 8-K, which included the related press release as an exhibit.

Technicians are also tracking whether the stock can punch through Thursday’s peak near $81.55, after shares whipsawed across a wide $73.50 to $81.55 band in the prior session. The stock’s previous close ahead of Thursday’s rally was $74.47, a handy nearby marker if pullback chatter picks up.

Chemicals were a mixed bag on Friday. Dow Inc added about 0.5%, while LyondellBasell and Olin each slipped roughly 0.5%, making Westlake’s move look more stock-specific than anything happening across the group.

The rebound leaves little room to get comfortable. If commodity spreads don’t loosen, or if housing and industrial demand don’t pick up, the stock’s rally could peter out fast — particularly while investors keep debating whether chemicals are actually bottoming or merely taking a breather.

Next on deck are earnings and 2026 guidance, where Westlake will need to spell out whether demand and pricing are finally stabilizing or still slipping. The company hasn’t put out a date, and Nasdaq’s earnings calendar currently lists Feb. 23 as an estimate for the next report.

Stock Market Today

  • Land Securities Group's Investment Outlook Shifts Amid Mixed Analyst Ratings
    April 29, 2026, 2:54 PM EDT. Land Securities Group (LSE:LAND) sees varied analyst outlooks. Goldman Sachs upgraded the stock with a fair value near £7.01, indicating optimism about fundamentals. Morgan Stanley maintains an Equal Weight rating, suggesting a balanced view with targets around £6.70. Meanwhile, Citi trimmed its price target by 23 GBp, signaling caution. Recent leasing deals, including bp's lease at Timber Square and strong tenant interest at MYO Kings Cross, underscore ongoing demand for Landsec's London office spaces. Timber Square's net zero design with Europe's tallest hybrid timber and steel building aligns with sustainability trends, potentially affecting future valuations. Investors should balance bullish upgrades against cautious price cuts as the investment story evolves.

Latest article

Why Rising Dragon Acquisition Stock Surged as RDAC Seeks More Time for HZJL SPAC Deal

Why Rising Dragon Acquisition Stock Surged as RDAC Seeks More Time for HZJL SPAC Deal

29 April 2026
Rising Dragon Acquisition Corp. shares surged over 400% to $21.72 Wednesday after the SPAC proposed extending its merger deadline with HZJL Cayman Limited. The company called a May 28 shareholder meeting to vote on extending the deadline by up to 15 months. Rising Dragon’s board urged shareholders to approve the extension. The HZJL merger has not closed.
Upstart Stock Falls After $1.25 Billion Fortress Deal: Why Investors Are Still Wary

Upstart Stock Falls After $1.25 Billion Fortress Deal: Why Investors Are Still Wary

29 April 2026
Upstart Holdings shares fell $2.09 to $30.77 Wednesday after announcing Fortress Investment Group affiliates will buy up to $1.25 billion in consumer loans over 15 months. March loan originations rose 60% year over year to $1.263 billion. In 2025, Upstart’s revenue climbed 64% to $1.0 billion, with net income of $53.6 million after a $129 million loss in 2024. Upstart plans to apply for a national bank charter.
Intel Stock Hits Record High as Google AI Chip Report Puts Foundry Turnaround in Play

Intel Stock Hits Record High as Google AI Chip Report Puts Foundry Turnaround in Play

29 April 2026
Intel shares surged 10% Wednesday after reports that Google may use Intel’s EMIB chip-packaging technology in its next AI processor. The stock hit $94.03 before settling at $93.23. Intel recently reported first-quarter revenue of $13.6 billion, up 7% year over year. CFO David Zinsner said some gains came from selling previously shelved chips.
Applied Digital (APLD) stock jumps again as hyperscaler AI data-center deals come into focus
Previous Story

Applied Digital (APLD) stock jumps again as hyperscaler AI data-center deals come into focus

Why Soleno Therapeutics stock is down today: investor alerts revive Vykat XR scrutiny
Next Story

Why Soleno Therapeutics stock is down today: investor alerts revive Vykat XR scrutiny

Go toTop